Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL

Approval Number

SIN15208P

Drug Name

CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL

Product Name

CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL

Approval Date

April 11, 2017

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

J01DD04

ATC Item Name

ceftriaxone

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

Qilu Pharmaceutical Co Ltd

Active Ingredients

Ingredient Name

CEFTRIAXONE SODIUM 2.159g eqv to CEFTRIAXONE BASE

Strength

2g/vial

Drug MonographCeftriaxone

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy